Aligos Therapeutics, Inc. — Investor Relations & Filings
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for liver and viral diseases. The company leverages expertise in medicinal chemistry and biology to create differentiated, best-in-class drug candidates for conditions with significant unmet medical needs. Its development pipeline features Pevifoscorvir sodium, an oral small molecule capsid assembly modulator (CAM-E) for chronic hepatitis B (CHB), and ALG-055009, an oral small molecule thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH). Aligos aims to develop therapies with enhanced pharmacologic properties suitable for both monotherapy and combination treatment regimens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-02-04 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 10-Q | 2025-11-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 34922357 | 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer) | 2026-04-21 | English | ||
| 31762692 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31762717 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31762711 | 8-K Filing | 2026-02-04 | English | ||
|
2025
11 filings
| |||||
| 13227302 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13227303 | 10-Q | 2025-11-06 | English | ||
| 13227304 | FORM 8-K | 2025-11-06 | English | ||
| 13227305 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13227306 | Major Shareholding Notification 2025 | 2025-08-13 | English | ||
| 13227307 | Major Shareholding Notification 2025 | 2025-08-12 | English | ||
| 13227308 | S-8 | 2025-08-06 | English | ||
| 13227309 | 10-Q | 2025-08-06 | English | ||
| 13227310 | FORM 8-K | 2025-08-06 | English | ||
| 13227311 | Director's Dealing 2025 | 2025-07-18 | English | ||
| 13227312 | Director's Dealing 2025 | 2025-07-18 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Aligos Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34431/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34431 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34431 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34431 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34431}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aligos Therapeutics, Inc. (id: 34431)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.